FDA label 2704d4c4-3214-4a67-80b3-233ae6fabab2

openFDA label record#

This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.

Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)

SPL set ID
b73f9b1f-aa6f-468f-880e-a7fa4bcf930b
SPL ID
2704d4c4-3214-4a67-80b3-233ae6fabab2
Version
3
Effective date
2019-09-10
Source export date
2026-11-06
Source partition
1
Source file
https://download.open.fda.gov/drug/label/drug-label-0001-of-0014.json.zip
Source object key
raw/openfda/drug-label/2026-11-06/d05434af5edc4383b7c7894a8f2d94df21171d17714450933cecdfc35cedfa3d/drug-label-0001-of-0014.json.zip
Source manifest SHA-256
4a7570ba105b5a039a8e1c94a85e7f085b9047a8882a35a96bf1e4516c5ffc97
Import run
20261108T063105Z
Imported at
2026-11-08 06:44:05

Warnings cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Warnings sections page 1 of 1 · 1 matching rows.

warnings

Warnings Do not use for more than 2 days without consulting a doctor. Ask a doctor before use if you have kidney disease hepatic or renal problems allergies to foods, preservatives, or dyes previously exhibited hypersensitivity to Phenazopyridine. Stop use and ask a doctor if symptoms persists for more than 2 days yellowish tinge of skin or sclera occurs When using this product stomach upset may occur a harmless reddish- orange color will be produced in the urine and may stain fabric staining of the contact lenses may also occur If pregnant or breast- feeding Ask a health care professional before use. Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.